Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Immunol ; 194(9): 4555-66, 2015 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-25825439

RESUMO

A key component in T cell activation is the endosomal recycling of receptors to the cell surface, thereby allowing continual integration of signaling and Ag recognition. One protein potentially involved in TCR transport is sorting nexin 17 (SNX17). SNX proteins have been found to bind proteins involved in T cell activation, but specifically the role of SNX17 in receptor recycling and T cell activation is unknown. Using immunofluorescence, we find that SNX17 colocalizes with TCR and localizes to the immune synapse in T- conjugates. Significantly, knockdown of the SNX17 resulted in fewer T-APC conjugates, lower CD69, TCR, and LFA-1 surface expression, as well as lower overall TCR recycling compared with control T cells. Lastly, we identified the 4.1/ezrin/radixin/moesin domain of SNX17 as being responsible in the binding and trafficking of TCR and LFA-1 to the cell surface. These data suggest that SNX17 plays a role in the maintenance of normal surface levels of activating receptors and integrins to permit optimum T cell activation at the immune synapse.


Assuntos
Integrinas/metabolismo , Ativação Linfocitária/imunologia , Receptores de Antígenos de Linfócitos T/metabolismo , Nexinas de Classificação/metabolismo , Subpopulações de Linfócitos T/imunologia , Subpopulações de Linfócitos T/metabolismo , Sequência de Aminoácidos , Linhagem Celular , Membrana Celular/metabolismo , Humanos , Sinapses Imunológicas/metabolismo , Células Jurkat , Ativação Linfocitária/genética , Antígeno-1 Associado à Função Linfocitária/metabolismo , Lisossomos/metabolismo , Dados de Sequência Molecular , Ligação Proteica , Domínios e Motivos de Interação entre Proteínas , Transporte Proteico , Proteólise , Alinhamento de Sequência , Nexinas de Classificação/química , Nexinas de Classificação/genética
2.
J Urol ; 194(3): 716-20, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25776908

RESUMO

PURPOSE: We evaluated perioperative complications in patients undergoing primary artificial urinary sphincter placement and the potential impact of these complications on device outcomes. MATERIALS AND METHODS: During the 2-year period from 2012 to 2014 we retrospectively evaluated the outcomes of 197 consecutive artificial urinary sphincter implantation procedures performed at our institution for post-prostatectomy incontinence. Of these cases 100 that were primary implantations comprise the study cohort. Perioperative complications, defined as those occurring within 6 weeks postoperatively, were classified by the Clavien-Dindo classification. After office evaluation at 6 weeks patients were followed for symptoms. Patient followup was obtained through office examination and telephone correspondence. RESULTS: Patients undergoing primary artificial urinary sphincter implantation had a median age of 71.5 years (IQR 66, 76). The overall rate of any complication (Clavien I-V) within 6 weeks of surgery was 35%, including urinary retention in 31% of cases, cellulitis in 1%, device infection in 2% and urethral erosion in 2%. No significant differences in pertinent clinical comorbidities such as age (p = 0.69), hypertension (p = 0.95), coronary artery disease (p = 0.57), diabetes mellitus (p = 0.17), body mass index (p = 0.47), prior pelvic radiation therapy (p = 0.45), prior urethral sling placement (p = 0.91) or transcorporeal urethral cuff placement (p = 0.22) were found between patients with and without complications. Median followup was similar between those with and without postoperative urinary retention (p = 0.14). Postoperative urinary retention was associated with adverse 6-month device survival (76% vs 89%, p = 0.04). CONCLUSIONS: The most common complication of artificial urinary sphincter placement is urinary retention. Serious adverse events following artificial urinary sphincter placement are rare. Postoperative urinary retention is associated with adverse short-term device survival rates.


Assuntos
Incontinência Urinária/cirurgia , Esfíncter Urinário Artificial/efeitos adversos , Idoso , Humanos , Masculino , Prostatectomia/efeitos adversos , Estudos Retrospectivos , Incontinência Urinária/etiologia , Retenção Urinária/etiologia
3.
Cell Rep ; 31(9): 107721, 2020 06 02.
Artigo em Inglês | MEDLINE | ID: mdl-32492429

RESUMO

Burkholderia cenocepacia is an opportunistic bacterial pathogen that causes severe pulmonary infections in cystic fibrosis and chronic granulomatous disease patients. B. cenocepacia can survive inside infected macrophages within the B. cenocepacia-containing vacuole (BcCV) and to elicit a severe inflammatory response. By inactivating the host macrophage Rho GTPases, the bacterial effector TecA causes depolymerization of the cortical actin cytoskeleton. In this study, we find that B. cenocepacia induces the formation of large cytosolic F-actin clusters in infected macrophages. Cluster formation requires the nucleation-promoting factor WASH, the Arp2/3 complex, and TecA. Inactivation of Rho GTPases by bacterial toxins is necessary and sufficient to induce the formation of the cytosolic actin clusters. By hijacking WASH and Arp2/3 activity, B. cenocepacia disrupts interactions with the endolysosomal system, thereby delaying the maturation of the BcCV.


Assuntos
Citoesqueleto de Actina/metabolismo , Burkholderia cenocepacia/fisiologia , Proteínas dos Microfilamentos/metabolismo , Fagossomos/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Proteínas rho de Ligação ao GTP/metabolismo , Complexo 2-3 de Proteínas Relacionadas à Actina/metabolismo , Animais , Toxinas Bacterianas/metabolismo , Células da Medula Óssea/citologia , Feminino , Lisossomos/metabolismo , Macrófagos/citologia , Macrófagos/imunologia , Macrófagos/metabolismo , Macrófagos/microbiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas dos Microfilamentos/deficiência , Proteínas dos Microfilamentos/genética , Células RAW 264.7 , Proteínas de Transporte Vesicular/deficiência , Proteínas de Transporte Vesicular/genética , Proteínas rho de Ligação ao GTP/antagonistas & inibidores
4.
PLoS One ; 9(6): e98606, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24886983

RESUMO

Immature dendritic cells (DCs) maintain a highly dynamic pool of recycling MHCII that promotes sampling of environmental antigens for presentation to T helper cells. However, the molecular basis of MHCII recycling and the cellular machinery that orchestrates MHCII trafficking are incompletely understood. Using a mouse model we show that WASH, an actin regulatory protein that facilitates retromer function, is essential for MHCII recycling and efficient priming of T helper cells. We further demonstrate that WASH deficiency results in impaired MHCII surface levels, recycling, and an accumulation of polyubiquitinated MHCII complexes, which are subsequently slated for premature lysosomal degradation. Consequently, conditional deletion of the Wash gene in DCs impairs priming of both conventional and autoimmune T helper cells in vivo and attenuates disease progression in a model of experimental autoimmune encephalitis (EAE). Thus, we identify a novel mechanism in which DCs employ the evolutionarily conserved WASH and retromer complex for MHCII recycling in order to regulate T helper cell priming.


Assuntos
Células Dendríticas/fisiologia , Antígenos de Histocompatibilidade Classe II/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Sequência de Bases , Primers do DNA , Encefalomielite Autoimune Experimental/imunologia , Ensaio de Imunoadsorção Enzimática , Antígenos de Histocompatibilidade Classe II/metabolismo , Lisossomos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Ubiquitinação
5.
Mol Cell Biol ; 33(5): 958-73, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23275443

RESUMO

WASH is an Arp2/3 activator of the Wiskott-Aldrich syndrome protein superfamily that functions during endosomal trafficking processes in collaboration with the retromer and sorting nexins, but its in vivo function has not been examined. To elucidate the physiological role of WASH in T cells, we generated a WASH conditional knockout (WASHout) mouse model. Using CD4(Cre) deletion, we found that thymocyte development and naive T cell activation are unaltered in the absence of WASH. Surprisingly, despite normal T cell receptor (TCR) signaling and interleukin-2 production, WASHout T cells demonstrate significantly reduced proliferative potential and fail to effectively induce experimental autoimmune encephalomyelitis. Interestingly, after activation, WASHout T cells fail to maintain surface levels of TCR, CD28, and LFA-1. Moreover, the levels of the glucose transporter, GLUT1, are also reduced compared to wild-type T cells. We further demonstrate that the loss of surface expression of these receptors in WASHout cells results from aberrant accumulation within the collapsed endosomal compartment, ultimately leading to degradation within the lysosome. Subsequently, activated WASHout T cells experience reduced glucose uptake and metabolic output. Thus, we found that WASH is a newly recognized regulator of TCR, CD28, LFA-1, and GLUT1 endosome-to-membrane recycling. Aberrant trafficking of these key T cell proteins may potentially lead to attenuated proliferation and effector function.


Assuntos
Proteínas dos Microfilamentos/genética , Proteínas dos Microfilamentos/imunologia , Receptores de Antígenos de Linfócitos T/imunologia , Linfócitos T/citologia , Linfócitos T/imunologia , Proteínas de Transporte Vesicular/genética , Proteínas de Transporte Vesicular/imunologia , Animais , Antígenos CD28/imunologia , Antígenos CD28/metabolismo , Antígenos CD4/genética , Antígenos CD4/imunologia , Proliferação de Células , Células Cultivadas , Encefalomielite Autoimune Experimental/genética , Encefalomielite Autoimune Experimental/imunologia , Deleção de Genes , Transportador de Glucose Tipo 1/imunologia , Transportador de Glucose Tipo 1/metabolismo , Glicólise , Interleucina-2/imunologia , Ativação Linfocitária , Antígeno-1 Associado à Função Linfocitária/imunologia , Antígeno-1 Associado à Função Linfocitária/metabolismo , Camundongos , Camundongos Knockout , Transporte Proteico , Receptores de Antígenos de Linfócitos T/metabolismo , Linfócitos T/metabolismo , Proteína da Síndrome de Wiskott-Aldrich/genética , Proteína da Síndrome de Wiskott-Aldrich/imunologia
7.
Arch Ophthalmol ; 128(9): 1166-9, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20837801

RESUMO

OBJECTIVE: To determine whether there is a relationship between congenital nasolacrimal duct obstruction (CNLDO) and subsequent refractive error disorders in children. METHODS: The medical records of children 5 years and younger diagnosed as having CNLDO between January 1, 2000, and December 31, 2007, were retrospectively reviewed. RESULTS: Three hundred five consecutive children were diagnosed as having CNLDO at a median age of 12.3 months (range, 0.8 months to 4.8 years). Thirty children (9.8%) were diagnosed as having anisometropia with (n = 16) or without (n = 14) amblyopia at a median age of 19.2 months (range, 3.6 months to 7.4 years). Twenty-six of the 30 patients had hyperopic anisometropia; more severe hyperopia occurred in the eye with CNLDO in 23 patients (88.5%), 2 patients had more severe hyperopia in the fellow eye, and 1 patient had bilateral CNLDO. The median initial (P = .005) and final (P < .001) refractive error was significantly more hyperopic in those with both CNLDO and anisometropia compared with those with CNLDO alone. CONCLUSIONS: The development of anisometropia with or without amblyopia seems to be more frequent in children examined by an ophthalmologist for CNLDO compared with that reported for the general public. The laterality of more severe hyperopia and amblyopia is generally on the side of the previous dacryostenosis.


Assuntos
Ambliopia/etiologia , Anisometropia/etiologia , Obstrução dos Ductos Lacrimais/congênito , Ducto Nasolacrimal/anormalidades , Criança , Pré-Escolar , Técnicas de Diagnóstico Oftalmológico , Feminino , Humanos , Lactente , Obstrução dos Ductos Lacrimais/diagnóstico , Masculino , Estudos Retrospectivos , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA